We found that T-GEP scores were significantly higher in EP300-mutated than in EP300-wild-type cancers in six cancer types, namely, BLCA, HNSC, UCEC, STAD, BRCA, and COAD (Figure 2C). The gene discussed is EP300; the disease is cancer.